Ligand validation:4QOJ

STL: RESVERATROL

STL is a Ligand Of Interest in 4QOJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QOJ_STL_B_302	83%	81%	0.097	0.957	0.2	0.61	-	-	0	0	100%	1
4QOJ_STL_A_302	81%	67%	0.099	0.951	0.27	0.97	-	-	1	0	100%	1
4QOH_STL_A_302	80%	53%	0.083	0.933	0.46	1.32	-	5	0	0	100%	1
1SG0_STL_B_502	22%	30%	0.187	0.8	2.45	0.52	11	-	1	0	100%	1
7Q9O_STL_A_201	92%	54%	0.08	0.972	1.1	0.66	2	-	0	0	100%	0.25
8CNO_STL_A_403	87%	32%	0.091	0.964	1.54	1.27	3	2	0	0	100%	1
8W42_STL_A_200	84%	43%	0.089	0.952	1.39	0.87	3	2	0	0	100%	0.25
7WAQ_STL_B_401	77%	50%	0.138	0.98	0.94	1.01	1	-	1	0	100%	1
2YDX_STL_A_502	64%	4%	0.171	0.972	3.92	2.05	11	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.